National Institute on Alcohol Abuse and Alcoholism; Notice of Meeting, 21200-21201 [2023-07439]

Download as PDF 21200 Federal Register / Vol. 88, No. 68 / Monday, April 10, 2023 / Notices technology to minimize the information collection burden. DEPARTMENT OF HEALTH AND HUMAN SERVICES Maria G. Button, Director, Executive Secretariat. National Institutes of Health [FR Doc. 2023–07410 Filed 4–7–23; 8:45 am] National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting ddrumheller on DSK120RN23PROD with NOTICES1 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Populationbased Research in Vector-borne Disease. Date: April 17, 2023. Time: 11:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Lisa Steele, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD 20892, (301) 257– 2638, steeleln@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: April 4, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–07404 Filed 4–7–23; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 18:13 Apr 07, 2023 Jkt 259001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Board of Scientific Counselors, NIAMS. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors, NIAMS. Date: May 2–3, 2023. Closed: May 02, 2023, 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate personnel qualifications and performance, and competence of individual investigators. Place: Porter Neuroscience Research Center, Building 35A, 620/630, 35 Convent Drive, Bethesda, MD 20892. Closed: May 03, 2023, 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate personnel qualifications and performance, and competence of individual investigators. Place: Porter Neuroscience Research Center, Building 35A, 620/630, 35 Convent Drive, Bethesda, MD 20892. Contact Person: John J. O’Shea, MD, Scientific Director of Intramural Research, National Institute of Arthritis & Musculoskeletal and Skin Diseases, Building 10, Bethesda, MD 20892, (301) 496–2612, osheaj@mail.nih.gov. In the interest of security, NIH has procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors attending a meeting on campus or at an off-campus federal facility will be asked to show one form of identification (for example, a governmentissued photo ID, driver’s license, or passport) and to state the purpose of their visit. Additional Health and Safety Guidance: Before attending a meeting at an NIH facility, it is important that visitors review the NIH COVID–19 Safety Plan at https:// ors.od.nih.gov/sr/dohs/safety/NIH-covid-19- PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 safety-plan/Pages/default.aspx and the NIH testing and assessment web page at https:// ors.od.nih.gov/sr/dohs/safety/NIH-covid-19safety-plan/COVID-assessment-testing/Pages/ visitor-testing-requirement.aspx for information about requirements and procedures for entering NIH facilities, especially when COVID–19 community levels are medium or high. In addition, the Safer Federal Workforce website has FAQs for visitors at https://www.saferfederal workforce.gov/faq/visitors/. Please note that if an individual has a COVID–19 diagnosis within 10 days of the meeting, that person must attend virtually. (For more information please read NIH’s Requirements for Persons after Exposure at https://ors.od.nih.gov/sr/ dohs/safety/NIH-covid-19-safety-plan/ COVID-assessment-testing/Pages/personsafter-exposure.aspx and What Happens When Someone Tests Positive at https:// ors.od.nih.gov/sr/dohs/safety/NIH-covid-19safety-plan/COVID-assessment-testing/Pages/ test-positive.aspx. Anyone from the public can attend the open portion of the meeting virtually via the NIH Videocasting website (https://videocast.nih.gov). Please continue checking these websites, in addition to the committee website listed below, for the most up to date guidance as the meeting date approaches. (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS) Dated: April 4, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–07403 Filed 4–7–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Council on Alcohol Abuse and Alcoholism. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https:// videocast.nih.gov/). A portion of this meeting will be closed to the public in accordance with E:\FR\FM\10APN1.SGM 10APN1 Federal Register / Vol. 88, No. 68 / Monday, April 10, 2023 / Notices ddrumheller on DSK120RN23PROD with NOTICES1 the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council on Alcohol Abuse and Alcoholism. Date: May 9, 2023. Closed: 10:00 a.m. to 10:45 a.m. Agenda: To review and evaluate grant applications. Open: 11:00 a.m. to 3:30 p.m. Agenda: Presentations and other business of the Council. Place: National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Conference Rooms A, B & C, 6700B Rockledge Drive, Bethesda, MD 20817. Contact Person: Ranga V. Srinivas, Ph.D., Acting Executive Secretary, National Advisory Council, Extramural Project Review Branch, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 6700 B Rockledge Drive, Room 2114, Bethesda, MD 20892, (301) 451–2067, srinivar@mail.nih.gov. Name of Committee: National Advisory Council on Alcohol Abuse and Alcoholism, National Cancer Advisory Board, and National Advisory Council on Drug Abuse. Date: May 10, 2022. Open: 10:00 a.m. to 3:30 p.m. Agenda: Presentation of NIAAA, NCI, and NIDA Director’s Update, Scientific Reports, and other topics within the scope of the Collaborative Research on Addiction at NIH (CRAN). Place: National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Conference Rooms A, B & C, 6700B Rockledge Drive, Bethesda, MD 20817. Contact Person: Ranga V. Srinivas, Ph.D., Acting Executive Secretary, National Advisory Council, Extramural Project Review Branch, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 6700 B Rockledge Drive, Room 2114, Bethesda, MD 20892, (301) 451–2067, srinivar@mail.nih.gov. Paulette S. Gray, Ph.D., Director, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 7W444, Bethesda, MD 20892, 240–276–6340, grayp@ dea.nci.nih.gov. Susan Weiss, Ph.D., Director, Division of Extramural Research, National Institute on Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, NSC, Room 5274, Bethesda, MD 20892, 301–443–6487, sweiss@ nida.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, VerDate Sep<11>2014 20:59 Apr 07, 2023 Jkt 259001 address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.niaaa.nih.gov/AboutNIAAA/ AdvisoryCouncil/Pages/default.aspx, where an agenda and any additional information for the meeting will be posted when available. Additional Health and Safety Guidance: Before attending a meeting at an NIH facility, it is important that visitors review the NIH COVID–19 Safety Plan at https://ors.od.nih.gov/sr/ dohs/safety/NIH-covid-19-safety-plan/ Pages/default.aspx for information about requirements and procedures for entering NIH facilities, especially when COVID–19 community levels are medium or high. In addition, the Safer Federal Workforce website has FAQs for visitors at https:// www.saferfederalworkforce.gov/faq/ visitors/. Please note that if an individual has a COVID–19 diagnosis within 10 days of the meeting, that person must attend virtually. (For more information, please read NIH’s Requirements for Persons after Exposure at https://ors.od.nih.gov/sr/dohs/safety/ NIH-covid-19-safety-plan/COVIDassessment-testing/Pages/persons-afterexposure.aspx and What Happens When Someone Tests Positive at https:// ors.od.nih.gov/sr/dohs/safety/NIHcovid-19-safety-plan/COVIDassessment-testing/Pages/testpositive.aspx.) Anyone from the public can attend the open portion of the meeting virtually via the NIH Videocasting website (https:// videocast.nih.gov). Please continue checking these websites, in addition to the committee website listed below, for the most up to date guidance as the meeting date approaches. (Catalogue of Federal Domestic Assistance Program Nos. 93.273, Alcohol Research Programs, National Institutes of Health, HHS) Dated: April 5, 2023. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–07439 Filed 4–7–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 21201 amended, notice is hereby given of a meeting of the Board of Scientific Counselors Chairs Meeting, Office of the Director, National Institutes of Health. The meeting will be held as a virtual meeting and is open to the public as indicated below. Individuals who plan to view the virtual meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Board of Scientific Counselors Chairs Meeting, National Institutes of Health. Date: May 12, 2023. Time: 12:00 p.m. to 3:00 p.m., EST. Agenda: The meeting will include a discussion of policies and procedures that apply to the regular review of NIH intramural scientists and their work. Place: National Institutes of Health, 1 Center Drive, Building 1, Room 160, Bethesda, MD 20892 (Zoom Meeting). This meeting is a virtual meeting via Zoom and can be accessed at: https:// nih.zoomgov.com/j/1605138302?pwd= b0VTMUhtSnBzOE5kcTJuSTR5akpYQT09. Meeting ID: 160 513 8302. Passcode: 183436. One tap mobile +16692545252,,1605138302#,,,,*183436# US (San Jose) +16468287666,,1605138302#,,,,*183436# US (New York) Dial by your location: +1 669 254 5252 US (San Jose) +1 646 828 7666 US (New York) +1 551 285 1373 US +1 669 216 1590 US (San Jose) Meeting ID: 160 513 8302. Passcode: 183436. Find your local number: https:// nih.zoomgov.com/u/acYh8huRe6. Contact Person: Margaret McBurney, Management Analyst, Office of the Deputy Director for Intramural Research, National Institutes of Health, 1 Center Drive, Room 160, Bethesda, MD 20892–0140, (301) 496– 1921, mmcburney@od.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Office of Intramural Research home page: https:// sourcebook.od.nih.gov/. Dated: April 5, 2023. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–07464 Filed 4–7–23; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\10APN1.SGM 10APN1

Agencies

[Federal Register Volume 88, Number 68 (Monday, April 10, 2023)]
[Notices]
[Pages 21200-21201]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07439]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Alcohol Abuse and Alcoholism; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Advisory 
Council on Alcohol Abuse and Alcoholism.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting. The open session will be 
videocast and can be accessed from the NIH Videocasting and Podcasting 
website (https://videocast.nih.gov/).
    A portion of this meeting will be closed to the public in 
accordance with

[[Page 21201]]

the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council on Alcohol Abuse 
and Alcoholism.
    Date: May 9, 2023.
    Closed: 10:00 a.m. to 10:45 a.m.
    Agenda: To review and evaluate grant applications.
    Open: 11:00 a.m. to 3:30 p.m.
    Agenda: Presentations and other business of the Council.
    Place: National Institutes of Health, National Institute on 
Alcohol Abuse and Alcoholism, Conference Rooms A, B & C, 6700B 
Rockledge Drive, Bethesda, MD 20817.
    Contact Person: Ranga V. Srinivas, Ph.D., Acting Executive 
Secretary, National Advisory Council, Extramural Project Review 
Branch, National Institute on Alcohol Abuse and Alcoholism, National 
Institutes of Health, 6700 B Rockledge Drive, Room 2114, Bethesda, 
MD 20892, (301) 451-2067, [email protected].

    Name of Committee: National Advisory Council on Alcohol Abuse 
and Alcoholism, National Cancer Advisory Board, and National 
Advisory Council on Drug Abuse.
    Date: May 10, 2022.
    Open: 10:00 a.m. to 3:30 p.m.
    Agenda: Presentation of NIAAA, NCI, and NIDA Director's Update, 
Scientific Reports, and other topics within the scope of the 
Collaborative Research on Addiction at NIH (CRAN).
    Place: National Institutes of Health, National Institute on 
Alcohol Abuse and Alcoholism, Conference Rooms A, B & C, 6700B 
Rockledge Drive, Bethesda, MD 20817.
    Contact Person: Ranga V. Srinivas, Ph.D., Acting Executive 
Secretary, National Advisory Council, Extramural Project Review 
Branch, National Institute on Alcohol Abuse and Alcoholism, National 
Institutes of Health, 6700 B Rockledge Drive, Room 2114, Bethesda, 
MD 20892, (301) 451-2067, [email protected].
    Paulette S. Gray, Ph.D., Director, Division of Extramural 
Activities, National Cancer Institute, National Institutes of 
Health, 9609 Medical Center Drive, Room 7W444, Bethesda, MD 20892, 
240-276-6340, [email protected].
    Susan Weiss, Ph.D., Director, Division of Extramural Research, 
National Institute on Drug Abuse, National Institutes of Health, 
6001 Executive Boulevard, NSC, Room 5274, Bethesda, MD 20892, 301-
443-6487, [email protected].

    Any interested person may file written comments with the committee 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person.
    Information is also available on the Institute's/Center's home 
page: https://www.niaaa.nih.gov/AboutNIAAA/AdvisoryCouncil/Pages/default.aspx, where an agenda and any additional information for the 
meeting will be posted when available.
    Additional Health and Safety Guidance: Before attending a meeting 
at an NIH facility, it is important that visitors review the NIH COVID-
19 Safety Plan at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/Pages/default.aspx for information about requirements and 
procedures for entering NIH facilities, especially when COVID-19 
community levels are medium or high. In addition, the Safer Federal 
Workforce website has FAQs for visitors at https://www.saferfederalworkforce.gov/faq/visitors/. Please note that if an 
individual has a COVID-19 diagnosis within 10 days of the meeting, that 
person must attend virtually. (For more information, please read NIH's 
Requirements for Persons after Exposure at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/persons-after-exposure.aspx and What Happens When Someone Tests 
Positive at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/test-positive.aspx.) Anyone from 
the public can attend the open portion of the meeting virtually via the 
NIH Videocasting website (https://videocast.nih.gov). Please continue 
checking these websites, in addition to the committee website listed 
below, for the most up to date guidance as the meeting date approaches.

(Catalogue of Federal Domestic Assistance Program Nos. 93.273, 
Alcohol Research Programs, National Institutes of Health, HHS)

    Dated: April 5, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-07439 Filed 4-7-23; 8:45 am]
BILLING CODE 4140-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.